An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: A report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)
Рекомендации по алгоритму ведения пациентов с остеоартритом коленного сустава в Европе и других странах мира: доклад рабочей группы Европейского общества по клиническим и экономическим аспектам остеопороза и остеоартрита (ESCEO)
2014-05-14
SCID: 54.1/s2tfcbpb
Discuss with AI
NSAIDsSymptomatic Slow-Acting Drugs for Osteoarthritisknee osteoarthritisnon-pharmacological treatmenttreatment algorithm
Figures from the paper
Abstract (AI)
OBJECTIVES: Existing practice guidelines for osteoarthritis (OA) analyze the evidence behind each proposed treatment but do not prioritize the interventions in a given sequence. The objective was to develop a treatment algorithm recommendation that is easier to interpret for the prescribing physician based on the available evidence and that is applicable in Europe and internationally. The knee was used as the model OA joint. METHODS: ESCEO assembled a task force of 13 international experts (rheumatologists, clinical epidemiologists, and clinical scientists). Existing guidelines were reviewed; all interventions listed and recent evidence were retrieved using established databases. A first schematic flow chart with treatment prioritization was discussed in a 1-day meeting and shaped to the treatment algorithm. Fine-tuning occurred by electronic communication and three consultation rounds until consensus. RESULTS: Basic principles consist of the need for a combined pharmacological and non-pharmacological treatment with a core set of initial measures, including information access/education, weight loss if overweight, and an appropriate exercise program. Four multimodal steps are then established. Step 1 consists of background therapy, either non-pharmacological (referral to a physical therapist for re-alignment treatment if needed and sequential introduction of further physical interventions initially and at any time thereafter) or pharmacological. The latter consists of chronic Symptomatic Slow-Acting Drugs for OA (e.g., prescription glucosamine sulfate and/or chondroitin sulfate) with paracetamol at-need; topical NSAIDs are added in the still symptomatic patient. Step 2 consists of the advanced pharmacological management in the persistent symptomatic patient and is centered on the use of oral COX-2 selective or non-selective NSAIDs, chosen based on concomitant risk factors, with intra-articular corticosteroids or hyaluronate for further symptom relief if insufficient. In Step 3, the last pharmacological attempts before surgery are represented by weak opioids and other central analgesics. Finally, Step 4 consists of end-stage disease management and surgery, with classical opioids as a difficult-to-manage alternative when surgery is contraindicated. CONCLUSIONS: The proposed treatment algorithm may represent a new framework for the development of future guidelines for the management of OA, more easily accessible to physicians.
Key Findings
1
Initial management combines pharmacological and non-pharmacological care, including education, weight loss for overweight patients, and an appropriate exercise program.
2
Recommendations were developed through review of existing guidelines and recent evidence, followed by multidisciplinary expert consensus and three consultation rounds.
3
Step 2 addresses persistent symptoms with oral selective or non-selective COX-2 NSAIDs selected according to patient risk factors, adding intra-articular corticosteroids or hyaluronate when needed.
4
The algorithm defines four multimodal treatment steps; Step 1 includes physical interventions, prescription glucosamine sulfate and/or chondroitin sulfate, as-needed paracetamol, and topical NSAIDs for persistent symptoms.
5
The task force developed an evidence-based, prioritized treatment algorithm for knee osteoarthritis intended for use in Europe and internationally.
Research Object
Knee osteoarthritis in Europe and internationally
Research Subject
Evidence-based prioritization and sequencing of combined pharmacological and non-pharmacological treatments for knee osteoarthritis
Publication Details
Publication Date
2014-05-14
Journal
Publisher
ISSN
Cited by
529
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai2
Cited by6
Sarcopenia in daily practice: assessment and management2016
An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)2019
Pharmaceutical-grade Chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versus CElecoxib versus Placebo Trial (CONCEPT)2017
Safety of Symptomatic Slow-Acting Drugs for Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis2019
Access to Highly Purified Chondroitin Sulfate for Appropriate Treatment of Osteoarthritis: A Review2017
Association of Pharmacological Treatments With Long-term Pain Control in Patients With Knee Osteoarthritis2018